Journal of Ovarian Research 2023

3 papers
The 2023 edition of the Journal of Ovarian Research emphasized the integration of radiomics and clinical data to enhance diagnostic and prognostic precision. A prominent theme involved the use of CT radiomics to predict biological markers, such as CXCL9 expression, and evaluate survival outcomes in ovarian cancer patients. Research also focused on clinical-radiomic fusion and the application of deep learning for comprehensive tumor assessment, addressing the challenges of generalizing medical AI across diverse clinical environments. Clinical management and genetic risk assessment were also central to the year's research. Studies investigated the outcomes of fertility-sparing management for synchronous primary neoplasms of the endometrium and ovary, alongside the implementation of risk-reducing salpingo-oophorectomy in high-risk populations. Methodological trends included the use of LASSO regularization for clinical prediction and the decoding of tumor phenotypes through high-dimensional data. Prolific contributors such as Donghui Pan, Feng Wang, and Min Yang published work aimed at bridging the gap between preoperative imaging and postoperative pathology.

Top Research Directions

The 14 research directions with Journal of Ovarian Research 2023 papers, ranked by paper count, next to 2022. Share is the fraction of the edition’s papers in the direction.

#Direction20232022Share 2023Share 20222022 rank
1Bridging the Biological Interpretability Gap in Radiomics1033.3%0.0%—
2Decoding Tissue Heterogeneity Through Quantitative Radiomics1033.3%0.0%—
3Differentiating Independent Primary Tumors from Metastatic Spread1033.3%0.0%—
4Extended Longitudinal Monitoring for Late Cancer Recurrence1033.3%0.0%—
5Generalizing Clinical Machine Learning Beyond Single Center Cohorts1033.3%0.0%—
6Integrating Radiomics and Clinical Data in Risk Nomograms1033.3%0.0%—
7Molecular Triggers of Pre-Malignant Tissue Transformation1033.3%0.0%—
8Moving Biomarkers from Retrospective Correlation to Clinical Utility1033.3%0.0%—
9Multimodal Fusion of Radiomics and Clinical Biomarkers1133.3%33.3%11
10Noninvasive Molecular Profiling via Radiogenomic Mapping1033.3%0.0%—
11Optimizing the Extent of Surgical Resection1033.3%0.0%—
12Overcoming Data Scarcity in Rare Disease Research1033.3%0.0%—
13Overcoming Tissue Sampling Bias via Quantitative Radiomics1033.3%0.0%—
14The Limits of Single Center Clinical Evidence1033.3%0.0%—

Download all directions as CSV

Institutions

Institutions credited by Journal of Ovarian Research 2023 papers: a paper credits every institution named in its affiliations, once. 5 institutions share 3 credited papers.

#InstitutionPapersShare20222022 rank
102hw73q19 133.3%0—
2Fudan University 133.3%11
3Jiangnan University 133.3%0—
4Nanjing Medical University 133.3%0—
5Sina (China) 133.3%0—

Download all institutions as CSV

About this data

Papers. Journal of Ovarian Research 2023 lists 3 papers on Lacuna, duplicate versions counted once; rejected and withdrawn submissions are left out.

Directions. Directions are Lacuna’s clustering of the concept elements extracted from each paper, so a paper can belong to several and direction counts add up to more than the paper count. A direction’s share is its papers divided by the edition’s papers. Comparisons with 2022 use shares, since the edition went from 3 to 3 papers.

Institutions. A paper credits each institution named in its affiliations, resolved to a ROR record, once. 3 of 3 papers (100.0%) credit at least one institution and are the base for institution shares; the rest have no resolved affiliation yet.

Data. Counts come from Lacuna’s data build of 2026-11-17 and change as papers are added. Tables as CSV: directions · institutions. Cite as: Lacuna, “Journal of Ovarian Research 2023”, https://lacuna.tiptreesystems.com/venue/journal-of-ovarian-research/2023.

Impactful Papers

Papers from Journal of Ovarian Research 2023 that shaped research clusters.

Influential

Papers

Title
CT radiomics prediction of CXCL9 expression and survival in ovarian cancer
Risk-reducing salpingo-oophorectomy among Chinese women at increased risk of breast and ovarian cancer
The pregnancy and oncology outcome of fertility-sparing management for synchronous primary neoplasm of endometrium and ovary